The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; MSD; Novartis; Roche
Speakers' Bureau - Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Pfizer; Roche
MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.
 
Fatima Cardoso
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; GE Healthcare; Genentech; GlaxoSmithKline; Macrogenics; Medscape; Merck Sharp & Dohme; Merus; Mundipharma; Mylan; Novartis; Pfizer; Pierre Fabre; Prime Oncology; Roche; Samsung Bioepis; Sanofi; Seagen; Teva
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Laura van 't Veer
Employment - Agendia
Leadership - Agendia
Stock and Other Ownership Interests - Agendia
 
Coralie Poncet
No Relationships to Disclose
 
Josephine Lopes Cardozo
No Relationships to Disclose
 
Suzette Delaloge
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Jean-Yves Pierga
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Genomic Health; Illumina; Ipsen; MSD Oncology; MSD Oncology (Inst); Novartis; Pfizer; Puma Biotechnology; Roche/Genentech; Roche/Genentech (Inst)
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca
 
Peter Vuylsteke
No Relationships to Disclose
 
Etienne Brain
Honoraria - Bristol-Myers Squibb; Mylan; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; G1 Therapeutics; Pfizer; Pfizer; Pfizer; Samsung; TLC PharmaChem
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Pierre Fabre; Roche; Sandoz
 
Giuseppe Viale
Honoraria - MSD Oncology; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer; Daiichi Sankyo; Dako; Menarini; MSD Oncology; Novartis; Roche/Genentech
Speakers' Bureau - Roche/Genentech
Research Funding - Cepheid (Inst); Dako/Agilent Technologies (Inst); Roche/Genentech; Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - Celgene; Roche
 
Sherko Kuemmel
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Genomic Health; Lilly; MSD Oncology; Novartis; Pfizer; pfm medical; Puma Biotechnology; Roche/Genentech; SOMATEX; Sonoscape
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche; Sonoscape
(OPTIONAL) Uncompensated Relationships - West German Study Group
 
Isabel T. Rubio
Honoraria - Roche
 
Gabriele Zoppoli
Research Funding - Thermo Fisher Scientific (Inst)
Patents, Royalties, Other Intellectual Property - AstraZeneca UK concerning methods for SLFN11 detection in cancer samples and its correlation with clinical outcome; Davide Bedognetti and Wouter Hendricxk from SIDRA Medicine, Doha, concerning in vitro experiments with SLFN11 and cancer models; European patent no. 102019000018989 concerning a "multi-domain method for prediction of one-year mortality in senior patients diagnosed with cancer"
Travel, Accommodations, Expenses - Novartis; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Breast International Group; Breast International Group/International Breast Cancer Study Group; European Organisation for Research and Treatment of Cancer (EORTC); Roche
 
Alastair Mark Thompson
Honoraria - Novartis (I); Pfizer
Travel, Accommodations, Expenses - Novartis (I); Pfizer
 
Erika Matos
Honoraria - Roche
Consulting or Advisory Role - Lilly; MSD; Novartis; Pfizer; Roche
 
Khalil Zaman
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Genomic Health (Inst); Lilly (Inst); MSD Oncology (Inst); Mylan (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Pfizer; Roche; Roche
 
Florentine Hilbers
Research Funding - Genentech/Roche (Inst); Novartis (Inst); Pfizer (Inst)
 
Aleksandra Dudek-Perić
Employment - TERUMO (I)
 
Bart Meulemans
No Relationships to Disclose
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - AstraZeneca; Camel-IDS; Crescendo Biologics; Debiopharm Group; G1 Therapeutics; HUYA Bioscience International; Immunomedics; Lilly; Menarini; MSD; Novartis; Odonate Therapeutics; Oncolytics; Periphagen; Pfizer; Radius Health; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Roche/Genentech (Inst); Servier (Inst); Synthon (Inst)
Other Relationship - Radius Health
 
Emiel J. Rutgers
No Relationships to Disclose